XiFin Pharmacy Solutions Seeks Insights from Pharmacy Professionals on Future Care Success
This American Pharmacists Month, XiFin Pharmacy Solutions invites pharmacy professionals to join the 2025 Pharmacy Transformation Study, which aims to identify key success factors shaping the future of pharmacy care. With growing evidence of pharmacists’ positive impact on health outcomes,…
14th Annual Spok Survey Reveals Insights on Healthcare Communications Challenges
Spok, Inc., a subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, has published its 14th annual survey on communication practices within U.S. healthcare organizations. This survey assesses how clinical communication is managed, highlighting trends, challenges,…
Otsuka Reports Positive Interim Phase 3 Results for Sibeprenlimab in Adult IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. have announced positive topline interim results from their ongoing Phase 3 clinical trial of sibeprenlimab for treating immunoglobulin A nephropathy (IgA nephropathy) in adults. Sibeprenlimab is an investigational anti-APRIL…
FDA Committee Backs CEL-SCI’s Multikine® for PD-L1 Negative Cancer Treatment
CEL-SCI Corporation (NYSE American: CVM) today highlighted the promising implications for its immunotherapy Multikine® (Leukocyte Interleukin, Injection) following a recent meeting of the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC), which serves as a public forum…
AMRA Study: Antidepressant Use Linked to Poor Muscle Health and Higher Cardiometabolic Risk
AMRA Medical, in collaboration with the University of Oslo, has published a study examining the effects of antidepressants (ADs), particularly serotonin-selective reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), on muscle health and cardiometabolic risk. Conducted as part of the CoMorMent…
Aptar Wins Federal Contract to Enhance Medical Device Sterilization Technology
AptarGroup, Inc. (NYSE: ATR), a global leader in dosing, dispensing, and protection technologies for drug and consumer products, has announced the award of a contract from the U.S. Federal Government to further develop its ActivShield™ technology. This innovative solution enables…
FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for At-Risk Adults 18-59
Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), a bivalent RSV vaccine, for preventing lower respiratory tract disease (LRTD) caused by RSV in individuals aged 18 to 59…
Hello Heart Enters Government Markets for Public Servants and Their Families
Hello Heart, a leader in preventive heart health, has announced its expansion into government markets across the United States. This initiative aims to make its proven heart health tools accessible to millions of Americans, allowing them to manage their health…
Hesperos, Inc. Names Lawrence Florin CEO for Growth Leadership
Hesperos, Inc., a leader in human biology modeling for drug development through its Human-on-a-Chip® technology, is excited to announce the appointment of Lawrence (Larry) Florin as Chief Executive Officer. With over 20 years of leadership experience in bio and clinical…
Alto Neuroscience Shares Phase 2b Results for ALTO-100 in Major Depression
Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on innovative treatments for neuropsychiatric disorders, announced today that its Phase 2b trial of ALTO-100 for major depressive disorder (MDD) did not achieve its primary endpoint, as measured by the…
Medpace Holdings, Inc. Announces Q3 2024 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) has announced its financial results for the third quarter ending September 30, 2024. Third Quarter 2024 Financial Highlights Year-to-Date 2024 Financial Overview Balance Sheet and Liquidity As of September 30, 2024, Medpace had cash and…
HSBC Report: AI and Trust to Transform Healthcare by 2035
According to the report “Health 2035: A Bold Path Through the Uncharted Future of Health,” published by HSBC Innovation Banking and The Linus Group, meaningful change in healthcare requires enhanced trust between physicians and patients, a reimagining of in-person interactions,…